Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Pax7tm1(cre)Mrc/?
B6.Cg-Pax7tm1(cre)Mrc Abcc6tm1c(EUCOMM)Wtsi
|
normal
integument phenotype |
J:252837
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: 129S2/SvPas * 129X1/SvJ * FVB
|
increased rhabdomyosarcoma incidence |
J:237183
|
|
increased sarcoma incidence |
J:237183
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7tm1Pgr
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: 129S2/SvPas * 129X1/SvJ * FVB
|
increased rhabdomyosarcoma incidence |
J:237183
|
|
increased sarcoma incidence |
J:237183
|
Dbx1tm1(DTA)Apie/Dbx1+
Pax7tm1(cre)Mrc/Pax7+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
normal
nervous system phenotype |
J:165285
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
Pax7tm1(cre/ERT2)Gaka/Pax7tm1(cre/ERT2)Gaka
Paxbp1tm1.1Nju/Paxbp1tm1.1Nju
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCr
|
abnormal mitochondrial ATP synthesis coupled electron transport |
J:304562
|
|
abnormal mitochondrial morphology |
J:304562
|
|
abnormal oxidative phosphorylation |
J:304562
|
|
abnormal respiratory electron transport chain |
J:304562
|
|
decreased mitochondrial fission |
J:304562
|
|
impaired skeletal muscle regeneration |
J:304562
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/?
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl
|
no abnormal phenotype detected |
J:256652
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Pax7tm1.1Fan/Pax7tm2.1(cre/ERT2)Fan
involves: 129 * C57BL/6 * SJL
|
abnormal muscle regeneration |
J:150962
|
|
abnormal myogenesis |
J:150962
|
|
normal
muscle phenotype |
J:150962
|
Gt(ROSA)26Sortm2(SS18)Mrc/Gt(ROSA)26Sortm2(SS18)Mrc
Pax7tm1(cre)Mrc/Pax7tm1(cre)Mrc
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
lethality throughout fetal growth and development, complete penetrance |
J:120967
|
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
Pax7tm1(cre)Mrc/Pax7tm1(cre)Mrc
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal muscle development |
J:120967
|
|
lethality throughout fetal growth and development, complete penetrance |
J:120967
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Kdm6atm1.1Kaig/Y
Pax7tm2.1(cre/ERT2)Fan/Pax7+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
impaired skeletal muscle regeneration |
J:232700
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Pax7tm1(cre)Mrc/Pax7+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal craniofacial morphology |
J:194308
|
|
lethality throughout fetal growth and development, complete penetrance |
J:194308
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S6/SvEvTac * C57BL/6
|
myopathy |
J:194308
|
|
normal
neoplasm |
J:194308
|
Kdm6atm1.1Kaig/Kdm6atm1.1Kaig
Pax7tm2.1(cre/ERT2)Fan/Pax7+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal muscle precursor cell morphology |
J:232700
|
|
impaired skeletal muscle regeneration |
J:232700
|
Kdm6atm1.1Kaig/Y
Pax7tm2.1(cre/ERT2)Fan/Pax7+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal muscle precursor cell morphology |
J:232700
|
|
impaired skeletal muscle regeneration |
J:232700
|
Krastm4Tyj/Kras+
Pax7tm2.1(cre/ERT2)Fan/Pax7+
Trp53tm1Brn/Trp53tm1Brn
involves: 129/Sv * 129P2/OlaHsd * 129X1/SvJ * C57BL/6
|
increased sarcoma incidence |
J:205518
|
|
increased tumor incidence |
J:205518
|
Mamstrtm1.1Eno/Mamstrtm1.1Eno
Pax7tm2.1(cre/ERT2)Fan/Pax7+
involves: 129 * C57BL/6
|
impaired skeletal muscle regeneration |
J:179880
|
Myf5tm1(cre)Mrc/Myf5+
Myod1tm1Jae/Myod1tm1Jae
Pax7tm1.1Thbr/Pax7tm1.1Thbr
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ
|
decreased satellite cell number |
J:202693
|
Myf5tm1Tajb/Myf5tm1Tajb
Pax7tm1.1Tajb/Pax7tm1.1Tajb
involves: 129S2/SvPas
|
abnormal extraocular muscle morphology |
J:150130
|
|
normal
muscle phenotype |
J:150130
|
Myh3tm1.2Sajm/Myh3tm1.1Sajm
Pax7tm1(cre)Mrc/Pax7+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J
|
abnormal muscle precursor cell morphology |
J:287755
|
|
normal
cellular phenotype |
J:287755
|
Pax3tm1.1Sjc/Pax3tm1.1Sjc
Pax7tm1.2Fan/Pax7tm1.2Fan
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129 * C57BL/6 * CBA * SJL
|
normal
muscle phenotype |
J:150962
|
Pax3tm1Buck/Pax3tm1Buck
Pax7tm2Pgr/Pax7tm2Pgr
either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) or (involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal myotome development |
J:99365
|
|
prenatal lethality, complete penetrance |
J:99365
|
Pax3tm1Mrc/Pax3+
Pax7tm1(cre)Mrc/Pax7+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal nose morphology |
J:93443
|
|
abnormal premaxilla morphology |
J:93443
|
|
decreased body weight |
J:93443
|
|
decreased satellite cell number |
J:93443
|
|
decreased skeletal muscle fiber diameter |
J:93443
|
|
decreased skeletal muscle mass |
J:93443
|
|
increased skeletal muscle fiber density |
J:93443
|
|
lacrimal bone hypoplasia |
J:93443
|
|
maxilla hypoplasia |
J:93443
|
|
muscle hypoplasia |
J:93443
|
|
normal
neoplasm |
J:93443
|
|
postnatal growth retardation |
J:93443
|
|
premature death |
J:93443
|
|
turbinate hypoplasia |
J:93443
|
Pax7tm1(cre)Mrc/Pax7tm1(cre)Mrc
Paxbp1tm1.1Nju/Paxbp1tm1.1Nju
involves: 129S1/Sv * 129X1/SvJ
|
embryonic lethality, complete penetrance |
J:304562
|
Pax7tm1(cre/ERT2)Gaka/Pax7+
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6
|
decreased satellite cell number |
J:174914
|
|
impaired skeletal muscle regeneration |
J:174914
|
|
skeletal muscle fibrosis |
J:174914
|
Pax7tm1(cre/ERT2)Gaka/0
Snhg15tm1.1Nju/Snhg15tm1.1Nju
involves: C57BL/6J * SJL/J
|
delayed skeletal muscle regeneration |
J:291983
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
involves: C57BL/6
|
decreased skeletal muscle mass |
J:180899
|
|
impaired skeletal muscle regeneration |
J:180899
|
|
normal
muscle phenotype |
J:180899
|
|
myositis |
J:180899
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
Tg(Pax7-EGFP)15Tajb/0
involves: C57BL/6 * SJL/J
|
abnormal muscle regeneration |
J:180899
|
|
decreased satellite cell number |
J:180899
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7tm1.1(HBEGF,-EYFP)Mal
involves: C57BL/6
|
decreased birth body size |
J:180899
|
|
premature death |
J:180899
|
Pax7tm1.1(rtTA)Sjl/Pax7tm1.1(rtTA)Sjl
Tg(Myl1-FST)F66Sjl/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
|
abnormal skeletal muscle fiber size |
J:188599
|
|
increased skeletal muscle weight |
J:188599
|
Prmt7tm1.1Rchd/Prmt7tm1.1Rchd
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6NCrl
|
abnormal muscle physiology |
J:271361
|
|
abnormal response to injury |
J:271361
|
|
early cellular replicative senescence |
J:271361
|
|
impaired skeletal muscle regeneration |
J:271361
|
Ptch1tm1Cklr/Ptch1+
Trp53tm1Brn/?
Pax7tm1(cre)Mrc/Pax7+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
|
increased medulloblastoma incidence |
J:159972
|
Ptch1tm1Cklr/Ptch1+
Pax7tm1(cre)Mrc/Pax7+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
|
ataxia |
J:159972
|
|
increased medulloblastoma incidence |
J:159972
|
Six1tm2.1Mair/Six1tm2.1Mair
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6Cr * C57BL/6NTac
|
abnormal muscle physiology |
J:190460
|
|
abnormal muscle regeneration |
J:190460
|
|
normal
muscle phenotype |
J:190460
|
|
skeletal muscle fibrosis |
J:190460
|
Zfp422em1Mode/Zfp422em1Mode
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl
|
abnormal myoblast differentiation |
J:297035
|
|
impaired skeletal muscle regeneration |
J:297035
|
Excel File
Analysis Tools